| 1. | | No longer recruiting | Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Conditions: recurrent adult acute lymphoblastic leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ... |
| 2. | | No longer recruiting | Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma; stage III melanoma; Recurrent Melanoma |
| 3. | | No longer recruiting | BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 4. | | No longer recruiting | BMS-188797 in Treating Patients With Advanced Solid Tumors That Have not Responded to Previous Treatment
Condition: unspecified adult solid tumor, protocol specific |
| 5. | | Completed | BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 6. | | Recruiting | Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 7. | | No longer recruiting | Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant
Conditions: Lymphoma; Multiple Myeloma; Leukemia |
| 8. | | Recruiting | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: extensive stage small cell lung cancer |
| 9. | | No longer recruiting | CI-994 in Treating Patients With Advanced Myeloma
Conditions: stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 10. | | Completed | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma |
| 11. | | No longer recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 12. | | No longer recruiting | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
Conditions: stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage IV breast cancer; recurrent breast cancer; ... |
| 13. | | No longer recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 14. | | Recruiting | Combination Chemotherapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 15. | | No longer recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 16. | | No longer recruiting | Comparison of Two Types of Biopsy in Patients With Breast Lesions That Cannot Be Felt Upon Examination
Condition: Breast Cancer |
| 17. | | No longer recruiting | CP-609,754 in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 18. | | Recruiting | Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
Conditions: Cachexia; childhood Hodgkin's lymphoma; childhood brain tumor; childhood non-Hodgkin's lymphoma; childhood solid tumor; ... |
| 19. | | Recruiting | Dextroamphetamine-Amphetamine Compared With Methylphenidate in Treating Children With Depression and Problems With Memory, Attention, and Thinking Caused By Cancer Treatment
Conditions: unspecified childhood solid tumor, protocol specific; Depression; neurotoxicity |
| 20. | | Recruiting | Donor Bone Marrow Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 21. | | No longer recruiting | Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
Conditions: stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer |
| 22. | | No longer recruiting | ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 23. | | No longer recruiting | Gemcitabine in Treating Elderly Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 24. | | No longer recruiting | Hydrocortisone Plus Aminoglutethimide or Ketoconazole in Treating Patients With Localized Stage IV Prostate Cancer
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer |
| 25. | | No longer recruiting | Interferon alfa Plus Radiation Therapy in Treating Patients With Stage III or Recurrent Melanoma That Has Been Removed by Surgery
Conditions: stage III melanoma; Recurrent Melanoma |
| 26. | | Completed | Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Conditions: lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 27. | | No longer recruiting | Irinotecan in Treating Patients With Newly Diagnosed or Relapsed Non- Hodgkin's Lymphoma or Leukemia
Conditions: Lymphoma; Leukemia |
| 28. | | Recruiting | Isoflavones Compared With Lycopene Before Surgery in Treating Patients With Stage I or Stage II Prostate Cancer
Conditions: stage I prostate cancer; stage II prostate cancer |
| 29. | | Recruiting | Isoflavones in Preventing Further Development of Cancer in Patients With Stage I or Stage II Prostate Cancer
Conditions: stage I prostate cancer; stage II prostate cancer |
| 30. | | No longer recruiting | Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or Lumpectomy
Condition: Breast Cancer |
| 31. | | No longer recruiting | Lymph Node Mapping and Sentinel Lymph Node Biopsy in Patients With Stage I, Stage II, or Stage III Colorectal Cancer
Conditions: stage I rectal cancer; stage I colon cancer; stage III colon cancer; stage III rectal cancer; stage II colon cancer; stage II rectal cancer |
| 32. | | No longer recruiting | Nitrocamptothecin Plus Etoposide in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 33. | | No longer recruiting | Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ... |
| 34. | | Completed | Phase II Study of R115777 in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 35. | | No longer recruiting | R115777 in Treating Patients With Advanced Bladder Cancer
Conditions: stage III bladder cancer; stage II bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; ... |
| 36. | | No longer recruiting | R115777 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 37. | | No longer recruiting | Radiolabeled SMT-487 in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer
Conditions: Male Breast Cancer; Recurrent Small Cell Lung Cancer; stage IV breast cancer; recurrent breast cancer |
| 38. | | No longer recruiting | Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Conditions: Leukemia; Multiple Myeloma |
| 39. | | Recruiting | Stress Management Training in Patients Undergoing Radiation Therapy for Cancer
Conditions: Quality of Life; Anxiety Disorder; Depression; unspecified adult solid tumor, protocol specific |
| 40. | | Recruiting | Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
Conditions: Drug Toxicity; hormonal changes; stage I breast cancer; stage II breast cancer |
| 41. | | Recruiting | Vaccine Therapy and Interleukin-2 in Treating Patients With Stage IV Kidney Cancer
Condition: Stage IV Renal Cell Cancer |
| 42. | | Recruiting | Vaccine Therapy With Either Neoadjuvant or Adjuvant Chemotherapy and Adjuvant Radiation Therapy in Treating Women With p53-Overexpressing Stage II or Stage III Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
| 43. | | No longer recruiting | Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 44. | | No longer recruiting | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Conditions: Lung Cancer; Melanoma; Lymphoma; Brain Tumor; Breast Cancer |
